ClinicalTrials.gov
ClinicalTrials.gov Menu

Registry for Eosinophilic Gastrointestinal Disorders (REGID) (EoE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01382563
Recruitment Status : Active, not recruiting
First Posted : June 27, 2011
Last Update Posted : January 23, 2017
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Develop Registry tool

Condition or disease
Eosinophilic Gastrointestinal Disorders (EGID) Eosinophilic Esophagitis Eosinophilic Disorder

Detailed Description:
The purpose of this research study is to develop a registry tool used for the management and care of patients with eosinophilic disorders, and create a research resource that will provide further insights into these disorders.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 10000 participants
Observational Model: Case-Only
Time Perspective: Other
Official Title: Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Study Start Date : November 2012
Estimated Primary Completion Date : December 2050
Estimated Study Completion Date : June 2051

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Registry Aim [ Time Frame: Open-ended ]
    The registry will allow for the standardization of care while also allowing us to identify gaps in care that need to be addressed and areas for future research at Cincinnati Children's Hospital Medical Center (CCHMC) and collaborating sites around the nation.


Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Eosinophilic Gastrointestinal Disorders
Criteria

Inclusion Criteria:

  • Eosinophilic Gastrointestinal Disorder diagnosis
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01382563


Locations
United States, California
Rady Children's Hospital
San Diego, California, United States, 92123-6791
United States, Colorado
The Children's Hospital
Aurora, Colorado, United States, 80045
United States, Illinois
Northwestern University School of Medicine
Chicago, Illinois, United States, 60611-2951
United States, Indiana
Riley Children's Hospital
Indianapolis, Indiana, United States, 46202
United States, North Carolina
University of North Carolina
Chapel Hill, North Carolina, United States, 25799
United States, Ohio
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229
United States, Pennsylvania
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Children's Hospital Medical Center, Cincinnati
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Principal Investigator: Marc E. Rothenberg, MD, PhD Children's Hospital Medical Center, Cincinnati
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier: NCT01382563     History of Changes
Other Study ID Numbers: 2010-1579
First Posted: June 27, 2011    Key Record Dates
Last Update Posted: January 23, 2017
Last Verified: January 2017

Keywords provided by Children's Hospital Medical Center, Cincinnati:
Eosinophilic Gastrointestinal Disorders
EGID
Eosinophilic Esophagitis
Registry
Eosinophils
Eosinophilia
 Eosinophilic enteropathy
Eosinophilic enteritis
Eosinophilic gastritis
Eosinophilic gastroenteritis
Eosinophilic gastroenteropathy

Additional relevant MeSH terms:
Disease
Esophagitis
Eosinophilic Esophagitis
Digestive System Diseases
Gastrointestinal Diseases
Eosinophilia
Pathologic Processes
 Esophageal Diseases
Gastroenteritis
Leukocyte Disorders
Hematologic Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases